在心血管疾病中的B型尿素
James A de Lemos1, Darren K McGuire, Mark H Drazner
1Donald W Reynolds Cardiovascular Clinical Research Center and Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9047, USA. james.delemos@utsouthwestern.edu <james.delemos@utsouthwestern.edu>
Lancet (London, England)
|August 2, 2003
概括
氨酸激素有助于诊断和治疗心血管疾病. 测量B型尿素 (BNP) 和N终端BNP有助于评估心力衰竭和预后.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 生物化学 生物化学
背景情况:
- 尿素是一种具有有益生理作用的血管活性激素.
- 它们在心血管疾病管理中至关重要.
- 翻译研究正在推进它们的临床应用.
研究的目的:
- 为了审查 natriuretic 系统的生理学.
- 讨论B型尿素 (BNP) 和N终端BNP在心力衰竭中的诊断和预后效用.
- 探索BNP和相关药物的治疗应用.
主要方法:
- 对尿酸的生理作用的综述.
- 对测量BNP和N终端BNP的临床研究的分析.
- 检查涉及BNP (尼西里提德) 和血管酶抑制剂的治疗策略.
主要成果:
- 在诊断心力衰竭和左心室功能障碍方面,BNP和N端BNP测量是有效的.
- 这些生物标志物还可以预测心脏病患者的预后.
- 涅西里提德和血管酶抑制剂在心力衰竭治疗中显示出潜在的潜力.
结论:
- 性尿素系统对于心血管健康和疾病管理至关重要.
- 像BNP和N-终端BNP这样的生物标志物具有重要的诊断和预后价值.
- 针对该系统的治疗干预措施有望改善患者的治疗结果.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...


